In an older adult with frontotemporal dementia, how can seizures be distinguished from abnormal muscle movements?

Distinguishing Seizures from Abnormal Muscle Movements in Frontotemporal Dementia

In older adults with frontotemporal dementia, use video-EEG monitoring with simultaneous EMG to definitively distinguish seizures from movement disorders, as clinical features alone are often insufficient and up to 10% of FTD patients develop seizures that can mimic dystonia or myoclonus.

Key Diagnostic Approach

The differentiation requires a structured, multi-dimensional assessment because seizures in FTD can present with subtle, atypical motor manifestations that overlap significantly with primary movement disorders 1.

Clinical Features That Favor Seizures

Temporal characteristics:

• Paroxysmal, stereotyped events lasting minutes to hours rather than continuous movements
• Sudden onset and offset with clear beginning and end points
• Episodes occur in discrete attacks rather than persistent throughout the day 2

Motor phenomenology:

• Rhythmic, shock-like muscular contractions (myoclonic jerks) rather than sustained postures
• Involvement of buccolingual region with jaw opening combined with limb movements
• Focal seizures are most common (50%), particularly temporal lobe epilepsy (42% of focal seizures) 3
• Generalized seizures occur in 29% of FTD patients with seizures 3

Associated features:

• Altered consciousness or responsiveness during or after events
• Post-ictal confusion or drowsiness
• Co-existing anxiety (present in 29% of FTD patients with seizures vs. 12% without) 3

Clinical Features That Favor Movement Disorders

• Continuous, daily occurrence of abnormal movements rather than discrete episodes 4
• Movements that vary in character and distribution
• Preserved consciousness throughout episodes
• Absence of post-event confusion
• Movements that can be temporarily suppressed or modified by distraction

Definitive Diagnostic Testing

Video-EEG with Polygraphic EMG Recording

This is the gold standard for differentiation 2. Look for:

Seizure indicators:

• High-amplitude (70-90 µV), 11-14 Hz bilaterally symmetric EEG rhythm over frontocentral regions
• Time-locked relationship between frontocentral EEG activity and EMG myoclonic potentials proves cortical origin and epileptic nature 2
• Brief, shock-like EMG bursts correlating with EEG discharges
• Clinical and EEG-EMG suppression with intravenous diazepam confirms epileptic etiology 2

Movement disorder indicators:

• No EEG correlate to abnormal movements
• EMG patterns showing sustained muscle contractions (dystonia) or variable patterns without EEG correlation

Neuroimaging Correlation

PET imaging findings 5:

• Temporal lobe hypometabolism is present in 86% of FTD patients with seizures versus 59% without seizures
• This finding, while not reaching statistical significance in current studies, provides supportive diagnostic evidence

MRI findings 5:

• 86% of FTD patients with seizures show MRI abnormalities
• Frontotemporal atrophy pattern predominates
• Mesial temporal sclerosis may be present
• Stroke detected in 7% of FTD patients with seizures

Critical Diagnostic Pitfalls

The Myoclonus-Dystonia Mimicry

Beware: Myoclonic status epilepticus in dementia patients can present with dystonia-like cervical postures and oromandibular symptoms that closely mimic primary movement disorders 2. The key differentiator is the rhythmic, shock-like quality of myoclonus versus sustained dystonic postures, but this requires video-EEG-EMG to confirm.

Subclinical Epileptiform Activity

Up to 42-54% of dementia patients have subclinical epileptiform activity on prolonged EEG monitoring that may manifest as subtle motor phenomena or cognitive fluctuations 6. Standard brief EEG may miss these findings—consider prolonged monitoring if clinical suspicion exists.

Behavioral Variant FTD Has Highest Seizure Risk

Seizures are most common in behavioral-variant FTD (54% of FTD patients with seizures have this subtype) 3, so maintain higher clinical suspicion in this population.

Treatment Implications

If seizures are confirmed:

• Levetiracetam is the most frequently used and well-tolerated antiseizure medication (38% of cases) 3
• Favorable prognosis: 87.5% of FTD patients with seizures achieve control on antiseizure medications 3
• Remaining cases may self-resolve without medication

Response to benzodiazepines:

• Acute suppression of both clinical symptoms and EEG-EMG correlates with IV diazepam strongly supports epileptic etiology 2
• This can serve as both diagnostic test and therapeutic intervention

When Distinction Is Impossible

Recognize that strict separation between seizures and movement disorders may not always be achievable, as myoclonic status epilepticus can involve both cortical (epileptic) and subcortical (dystonic) structures simultaneously 2. In such cases, empirical treatment with antiseizure medications is reasonable given the favorable response rate and the potential for subclinical epileptiform activity to accelerate cognitive decline (1.5-fold faster progression) 6.